NCT02471274View on ClinicalTrials.gov

PK Study of Sotagliflozin in Subjects With Hepatic Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2015

Conditions
Hepatic ImpairmentHealthy
Interventions
DRUG

sotagliflozin

single 400 mg dose

Trial Locations (4)

32809

Lexicon Investigational Site, Orlando

33014

Lexicon Investigational Site, Miami

55404

Lexicon Investigational Site, Minneapolis

80228

Lexicon Investigational Site, Lakewood

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY